跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,681 条关于
“Saturn V Capital Management LP”
全部
31,681
临床试验
19,837
药物
726
机构
370
资讯
10,748
9个月前
Dyne Therapeutics Stock Plunges 17% Following $300 Million Secondary Offering Despite DMD Trial Success
11个月前
Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
6个月前
Superstring Capital Management Invests $6.84 Million in CNS Drug Developer Axsome Therapeutics
6个月前
ACT Capital Management Invests $8 Million in TG Therapeutics Despite 30% Stock Decline
9个月前
Tang Capital Management Invests $56.8 Million in Celcuity Following Positive Phase 3 Gedatolisib Results
2年前
Telisotuzumab Vedotin Improves Patient-Reported Outcomes in c-Met+ NSCLC
去年
EMA Official Warns Against Unilateral Sputnik V Authorization, Cites Safety Concerns
去年
Johnson & Johnson Acquires V-Wave, Bolstering Heart Failure Portfolio with Ventura Shunt
去年
Lp(a)-Lowering Therapies Show Promise in Phase II Trials
第 1 页，共 1075 页
上一页
下一页
